Webinar
Breaking Down the Hottest Topic in Pharmacy:
Humira Biosimilars
Uncover what could happen with Humira and the biosimilar market in 2023
While biosimilars have existed for many years, the topic has been gaining some serious new attention as AbbVie’s Humira—the number one selling drug in the U.S.—no longer has exclusivity in the market.
Will biosimilar competitors increase competition, lower drug costs and knock Humira out of the top spot? It’s the top question our clinical pharmacists and industry experts are being asked to comment on. We’re sharing all the facts—and some of our own predictions—in our webinar.
Join us to learn:
- How Humira dominated the autoimmune market
- The Humira biosimilar competition
- Our predictions for 2023 and beyond
- Recommended next steps for industry stakeholders
If you’re a health plan, employer group, biosimilar manufacturer, PBM, broker, TPA, or a patient—you won’t want to miss it.
Get Access Today!
Meet the Speakers:
.png?width=200&height=200&name=Patrick%20circle%20(4).png "Patrick circle (4)")
Ralph Pisano
President, Nuwae
With over 20 years of experience, Ralph is a well-respected name within healthcare and has helped significantly lower medical and pharmacy costs while improving outcomes through various programs covering millions of lives. As President of Nuwae, Ralph will continue championing solutions that lower out-of-pocket drug costs by disrupting the inflated supply-chain profit that exists today.
Jason Peterson, R.Ph
Clinical Pharmacist, Remedyone
With over 15 years of pharmacy benefit management experience, Jason Peterson is a key member of the clinical team overseeing RemedyOne formulary management, clinical policy development, pipeline reporting and trend analysis of pharmacy benefits for our clients. Jason’s experience is leveraged to identify spend and trend analysis of both pharmacy and medical benefit cost of care and utilization to identify opportunities for enhanced clinical effectiveness and savings.
.png?width=200&height=200&name=Patrick%20circle%20(2).png "Patrick circle (2)")
Scott Wert
VP, Contracting & Strategy, Nuwae
As Contracting & Strategy Vice President, Scott is responsible for realizing Nuwae's mission of driving transparency, lower administrative cost, aggressive rebates, and contracts that deliver the lowest net cost to all clients and individual patients. With almost 30 years of pharmaceutical leadership experience in managed negotiation, execution and administration of pharmacy and medical solutions, Scott is essential to Nuwae’s innovative solutions focused on resolving the issues that cause skyrocketing drug pricing.
